ACR2022 - Day 3.0

Best of ACR Day Two in PSA
Dr. Rachel Tate, discusses abstracts 1018, 1159 at ACR22 Convergence.

Comorbidities in Ankylosing Spondylitis
Dr. Akhil Sood discusses Abstract 1609 at ACR22 Convergence.

Fat and bone are never alone: osteoporotic fracture in RA
Dr. David Liew discusses Abstract 889 at ACR22 Convergence. 
Abstract 889: Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis

GCA: What we feel and what we can't
Dr David Liew discusses Abstracts 0483 and 0486 at ACR22 Convergence.

Hydroxychloroquine: Cumulative Doses and Thresholds
Dr. Sheila Reyes discusses Abstracts 0982 and 0344 at ACR22 Convergence.

JAK inhibitors in rheumatic diseases
Dr. Antoni Chan discusses abstracts 0510 and 0404 at ACR22 Convergence in Philadelphia, PA.
Abstract 0510: MACE and VTE Across Upadacitinib Clinical Trial Programs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Abstract 0404: Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial

Low-grade Proteinuria in Non-Renal Lupus: Should We be Worried?
Dr. Yuz Yusof discusses Abstract 1463 presented at ACR22 Convergence in Philadelphia, PA.

PET CT Imaging to Define Risk of Progression from PSO to PsA
Dr. Peter Nash discusses Abstract 1018 at ACR22 Convergence.

Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler discusses the following abstracts presented at ACR22 Convergence. 
Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)

Tapering TNF Inhib in non Radiolgraphic AxSpA
Dr. Peter Nash, Philadelphia

Vaccines Work!
Dr. Eric Dein and Dr. Caoilfhionn Connolly discuss abstracts 2275 & 0797 at ACR22 Convergence.